자궁경 검사 시술 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 수기별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Hysteroscopy Procedures Market Size, Share & Trends Analysis Report By Procedure (CPT Code 58558, CPT Code 58562), By End Use (Ambulatory Surgical Centers, Hospitals, Clinics), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,590,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,034,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,922,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

자궁경 검사 시술 시장의 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 자궁경 검사 시술 시장 규모는 2025-2030년 CAGR 7.7%로 확대될 전망이며, 2030년에는 74억 달러에 이를 전망입니다.

부인과 질환의 유병률 급증, 기술의 진보, 저침습 수술의 채용 증가, 유리한 상환 정책이 시장의 주요 촉진요인입니다. 게다가 코로나19 팬데믹 시장에 대한 영향도 큽니다.

팬데믹은 기업의 신제품 및 첨단 제품의 개발과 상품화 능력에 영향을 미치고 있습니다. 거의 모든 기업이 팬데믹으로 인한 수술 건수 감소의 영향을 받았습니다. 또한 제한된 수의 관공서의 제한과 기능으로 인해 제품의 임상시험이 지연될 것으로 예상되며, 그 결과 기업에 의한 제품 출시가 지연될 것으로 예상됩니다.

자궁 근종의 유병률 증가는 시장을 견인하는 중요한 요소입니다. 예를 들어 Dove Press Ltd.에 게재된 조사 기사에 따르면, 자궁근종의 유병률은 연령층에 따라 5.4%에서 23.6%에 이릅니다. 게다가 자궁근종은 25%의 여성에게 심각한 문제를 일으킬 수 있습니다. 자궁경 검사는 과다 출혈, 심한 복통, 반복 유산, 임신 곤란 등의 이상을 진단하기 위해 시행됩니다. 따라서 이러한 대규모 환자 풀의 존재는 자궁경 검사 시술 절차의 수요 증가로 이어집니다.

자궁경 검사 시술 시장 보고서 및 하이라이트

• 병원의 최종 용도 부문은 2024년에 52.4% 이상의 최대의 수익 점유율을 차지했습니다. 이 부문의 성장은 부인과 질환의 증례 수가 많기 때문이다.
• 아시아태평양은 APAC 지역에서 고령화 인구 증가와 함께 대규모 환자 풀이 존재하기 때문에 예측 기간 중에 가장 빠른 CAGR을 나타낼 것으로 기대됩니다.
• 자궁경 검사를 오피스 진료에 통합하는 것은 주요 시장 기업에게 유리한 기회를 제공합니다. 몇몇 기업이 오피스 자궁경 검사와 관련 기기를 출시하고 있습니다.
• 예를 들어 최근 Meditrina Inc.가 2020년 3월에 출시한 Aveta System(오피스 자궁경 검사)은 자궁내 병리를 위한 올인원 조직 제거 솔루션으로 광각 HD 자궁경 검사를 제공합니다.
• 또한 오피스 자궁경 검사는 효율적이고 임상적으로 유익하며 환자 중심의 접근법을 제공하기 때문에 기존의 자궁경 검사 절차보다 유익합니다.
• 또한 자궁내 피임구를 꺼내기 위한 간단하고 신속한 도구이기도 합니다. 따라서 의사는 자궁경 검사 기기에 투자하고 사무실 내 접근 방식을 채택하는 것을 검토할 것으로 보입니다.

목차

제1장 조사 방법 및 범위

제2장 주요 요약

제3장 자궁경 검사 시술 시장의 변수, 동향 및 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련 및 부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 자궁경 검사 시술 시장 분석 툴
  • 업계 분석-Porter's Five Forces 분석
  • PESTEL 분석

제4장 자궁경 검사 시술 시장 : CPT 코드별 추정 및 동향 분석

• 부문 대시보드
• 자궁경 검사 시술 시장 : CPT 코드별 변동 분석
• CPT 코드 별 자궁경 검사 시술 시장 전망
• 시장 규모와 예측 및 동향 분석(2018-2030년)
• 58555
• 58558
• 58562
• 58340
• 58563
• 58565
• 58353
• 58561,74740 이상(기타)

제5장 자궁경 검사 시술 시장 : 최종 용도별 추정 및 동향 분석

• 부문 대시보드
• 자궁경 검사 시술 시장 : 최종 용도별 변동 분석
• 자궁경 검사 시술 시장 : 최종 용도별 전망
• 시장 규모와 예측 및 동향 분석(2018-2030년)
• 병원
• 클리닉
• 외래수술센터(ASC)

제6장 자궁경 검사 시술 시장 : 지역별 추정 및 동향 분석

• 지역별 대시보드
• 지역별 자궁경 검사 시술 시장 변동 분석
• 자궁경 검사 시술 시장 : CPT 코드별, 최종 용도별 및 지역별 추정 및 동향 분석
• 시장 규모와 예측 및 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
  • 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 라틴아메리카 자궁경 검사 시술 시장 추계 및 예측(2018-2030년)
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카의 자궁경 검사 시술 시장 추계 및 예측(2018-2030년)
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 시장 진출 기업의 분류
• 주요 기업 프로파일
  • Medtronic
  • Stryker Corporation
  • Hologic, Inc.
  • KARL STORZ SE & CO. KG
  • Johnson &Johnson(Ethicon, Inc)
  • Olympus Corp.
  • Delmont Imaging
  • B. Braun Melsungen AG
  • Richard Wolf GmbH
  • CooperCompanies
  • Maxer Endoscopy GmbH
  • Boston Scientific Corp.
  • MedGyn Products, Inc.
  • Lina Medical APS
  • Luminelle
  • Meditrina, Inc.(Aveta)

AJY

영문 목차

영문목차

Hysteroscopy Procedures Market Growth & Trends:

The global hysteroscopy procedures market size is expected to reach USD 7.4 billion by 2030, expanding at a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Surge in prevalence of gynecological disorders, technological advancements, increasing adoption of minimally invasive surgeries, and favorable reimbursement policies are the key driving factors for the market. In addition, the impact of the COVID-19 pandemic has been significant on the market.

The pandemic has affected companies' ability to develop and commercialize new & advanced products. Almost all companies are affected by reduced procedure volumes due to the pandemic, as all hospital resources are being diverted to fight the disease. Furthermore, the restrictions and functioning of a limited number of government offices are expected to delay clinical trials of products, which is expected to result in delayed product launches by companies.

The increasing prevalence of uterine fibroids is a key factor driving the market. For instance, as per the research article published in Dove Press Ltd., the prevalence of uterine fibroid disease ranges from 5.4% to 23.6%, depending upon the age group. Moreover, uterine fibroids can cause serious problems in 25% of women. Hysteroscopy is used to diagnose abnormalities, such as excessive bleeding, severe stomach cramps, recurrent miscarriages, or difficulties in conceiving. Thus, the presence of such a large patient pool leads to increased demand for hysteroscopy procedures.

Hysteroscopy Procedures Market Report Highlights:

• The hospitals end-use segment held the largest revenue share of over 52.4% in 2024. The segment growth is credited to the high number of cases of gynecological disorders
• Asia Pacific is expected to witness the fastest CAGR over the forecast period due to the presence of a large patient pool coupled with the rising aging population in the APAC region
• Integrating hysteroscopy into office practice will provide a lucrative opportunity for key market players. Several players have launched office hysteroscopy and associated devices
• For instance, Aveta System (office hysteroscopy), recently launched by Meditrina Inc. in March 2020, is an all-in-one tissue removal solution for intrauterine pathology, which offers wide-angle HD hysteroscopy
• Furthermore, in-office hysteroscopy is beneficial over traditional hysteroscopy procedures as it is efficient & clinically beneficial and offers a patient-centric approach
• It is also a simple and quick tool for retrieving intrauterine devices. Thus, physicians will consider investing in equipment and adopting an in-office approach for hysteroscopy

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. CPT Codes
  • 1.1.2. End Use
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. CPT Codes outlook
  • 2.2.2. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Hysteroscopy Procedures Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of gynecological disorders
    • 3.2.1.2. Rising adoption of minimally invasive surgical procedures
    • 3.2.1.3. Growing adoption of technologically advanced devices for hysteroscopy procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of hysteroscopy procedures and systems
    • 3.2.2.2. Concerns associated with product approval and commercialization
• 3.3. Hysteroscopy Procedures Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Hysteroscopy Procedures Market: CPT Codes Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Hysteroscopy Procedures Market: CPT Codes Movement Analysis
• 4.3. Hysteroscopy Procedures Market by CPT Codes Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. 58555
  • 4.5.1. 58555 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. 58558
  • 4.6.1. 58558 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. 58562
  • 4.7.1. 58562 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. 58340
  • 4.8.1. 58340 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. 58563
  • 4.9.1. 58563 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.10. 58565
  • 4.10.1. 58565 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.11. 58353
  • 4.11.1. 58353 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.12. 58561,74740 and more (Others)
  • 4.12.1. 58561, 74740 and more (Others) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Hysteroscopy Procedures Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Hysteroscopy Procedures Market: End Use Movement Analysis
• 5.3. Hysteroscopy Procedures Market by End Use Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Hospitals
  • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Clinics
  • 5.6.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Ambulatory Surgery Centers
  • 5.7.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hysteroscopy Procedures Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Hysteroscopy Procedures Market movement analysis
• 6.3. Hysteroscopy Procedures Market: Regional Estimates & Trend Analysis by CPT Codes & End-use
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. Canada Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Europe
  • 6.5.6. Europe Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. UK
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Reimbursement scenario
    • 6.5.7.5. UK Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Germany
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Reimbursement scenario
    • 6.5.8.5. Germany Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. France
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Reimbursement scenario
    • 6.5.9.5. France Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.10. Italy
    • 6.5.10.1. Key Country Dynamics
    • 6.5.10.2. Competitive Scenario
    • 6.5.10.3. Regulatory Framework
    • 6.5.10.4. Reimbursement scenario
    • 6.5.10.5. Italy Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.11. Spain
    • 6.5.11.1. Key Country Dynamics
    • 6.5.11.2. Competitive Scenario
    • 6.5.11.3. Regulatory Framework
    • 6.5.11.4. Reimbursement scenario
    • 6.5.11.5. Spain Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.12. Denmark
    • 6.5.12.1. Key Country Dynamics
    • 6.5.12.2. Competitive Scenario
    • 6.5.12.3. Regulatory Framework
    • 6.5.12.4. Reimbursement scenario
    • 6.5.12.5. Denmark Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.13. Sweden
    • 6.5.13.1. Key Country Dynamics
    • 6.5.13.2. Competitive Scenario
    • 6.5.13.3. Regulatory Framework
    • 6.5.13.4. Reimbursement scenario
    • 6.5.13.5. Sweden Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.14. Norway
    • 6.5.14.1. Key Country Dynamics
    • 6.5.14.2. Competitive Scenario
    • 6.5.14.3. Regulatory Framework
    • 6.5.14.4. Reimbursement scenario
    • 6.5.14.5. Norway Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • . Asia Pacific Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. Japan Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. China Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. India Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. South Korea Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Australia Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Thailand Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Brazil Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. Argentina Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Middle East & Africa
  • 6.8.1. Middle East & Africa Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. South Africa Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Saudi Arabia Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. Reimbursement scenario
    • 6.8.4.5. UAE Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Reimbursement scenario
    • 6.8.5.5. Kuwait Hysteroscopy Procedures Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Medtronic
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Stryker Corporation
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Hologic, Inc.
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. KARL STORZ SE & CO. KG
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Johnson & Johnson (Ethicon, Inc)
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Olympus Corp.
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Delmont Imaging
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. B. Braun Melsungen AG
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. Richard Wolf GmbH
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. CooperCompanies
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. Maxer Endoscopy GmbH
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives
  • 7.2.12. Boston Scientific Corp.
    • 7.2.12.1. Company overview
    • 7.2.12.2. Financial performance
    • 7.2.12.3. Product benchmarking
    • 7.2.12.4. Strategic initiatives
  • 7.2.13. MedGyn Products, Inc.
    • 7.2.13.1. Company overview
    • 7.2.13.2. Financial performance
    • 7.2.13.3. Product benchmarking
    • 7.2.13.4. Strategic initiatives
  • 7.2.14. Lina Medical APS
    • 7.2.14.1. Company overview
    • 7.2.14.2. Financial performance
    • 7.2.14.3. Product benchmarking
    • 7.2.14.4. Strategic initiatives
  • 7.2.15. Luminelle
    • 7.2.15.1. Company overview
    • 7.2.15.2. Financial performance
    • 7.2.15.3. Product benchmarking
    • 7.2.15.4. Strategic initiatives
  • 7.2.16. Meditrina, Inc. (Aveta)
    • 7.2.16.1. Company overview
    • 7.2.16.2. Financial performance
    • 7.2.16.3. Product benchmarking
    • 7.2.16.4. Strategic initiatives

관련자료